Logo: to the web site of Uppsala University
uu.se
Publications from Uppsala University
Please wait ...
Simple search
Advanced search -
Research publications
Advanced search -
Student theses
Statistics
English
Svenska
Norsk
Jump to content
Change search
Search
Search
Only documents with full text in DiVA
Cite
Export
BibTex
CSL-JSON
CSV 1
CSV 2
CSV 3
CSV 4
CSV 5
CSV all metadata
CSV all metadata version 2
RIS
Mods
MARC-XML
ETDMS
Link to record
Permanent link
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-469998
Direct link
http://uu.diva-portal.org/smash/record.jsf?pid=diva2:1645628
Cite
Citation style
apa
ieee
modern-language-association
vancouver
Other style
apa
ieee
modern-language-association
vancouver
Other style
More styles
Language
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
More languages
Output format
html
text
asciidoc
rtf
html
text
asciidoc
rtf
Create
Close
How can we optimize the development of drugs for wound healing?
Vågesjö, Evelina
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology. Ilya Pharma AB, Uppsala, Sweden.
ORCID iD:
0000-0002-4254-6875
Grigoleit, Patricia
Ilya Pharma AB, Uppsala, Sweden..
Fasth, Andreas
Ilya Pharma AB, Uppsala, Sweden..
Phillipson, Mia
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology. Uppsala University, Science for Life Laboratory, SciLifeLab.
ORCID iD:
0000-0002-2387-0266
2022 (English)
In:
Expert Opinion on Drug Discovery, ISSN 1746-0441, E-ISSN 1746-045X, Vol. 17, no 2, p. 93-96
Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
Taylor & Francis Taylor & Francis, 2022. Vol. 17, no 2, p. 93-96
National Category
Pharmaceutical Sciences Pharmacology and Toxicology
Identifiers
URN:
urn:nbn:se:uu:diva-469998
DOI:
10.1080/17460441.2022.1992381
ISI:
000709193100001
PubMedID:
34651533
OAI: oai:DiVA.org:uu-469998
DiVA, id:
diva2:1645628
Funder
EU, Horizon 2020, 804438
EU, Horizon 2020, 960913
Swedish Research Council
Knut and Alice Wallenberg Foundation
Vinnova
Available from:
2022-03-18
Created:
2022-03-18
Last updated:
2024-01-15
Bibliographically approved
Open Access in DiVA
No full text in DiVA
Other links
Publisher's full text
PubMed
Authority records
Vågesjö, Evelina
Phillipson, Mia
Search in DiVA
By author/editor
Vågesjö, Evelina
Phillipson, Mia
By organisation
Department of Medical Cell Biology
Science for Life Laboratory, SciLifeLab
In the same journal
Expert Opinion on Drug Discovery
On the subject
Pharmaceutical Sciences
Pharmacology and Toxicology
Search outside of DiVA
Google
Google Scholar
doi
pubmed
urn-nbn
Altmetric score
doi
pubmed
urn-nbn
Total: 136 hits
Cite
Export
BibTex
CSL-JSON
CSV 1
CSV 2
CSV 3
CSV 4
CSV 5
CSV all metadata
CSV all metadata version 2
RIS
Mods
MARC-XML
ETDMS
Link to record
Permanent link
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-469998
Direct link
http://uu.diva-portal.org/smash/record.jsf?pid=diva2:1645628
Cite
Citation style
apa
ieee
modern-language-association
vancouver
Other style
apa
ieee
modern-language-association
vancouver
Other style
More styles
Language
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
More languages
Output format
html
text
asciidoc
rtf
html
text
asciidoc
rtf
Create
Close
v. 2.46.0
|
WCAG
|
Uppsala University Library
|
Ask the Library
|
Log in to DiVA
|
Search and link in DiVA
DiVA
Logotyp